Skip to main content
TheOIGuy.com LLC
Menu
  • External link opens in new tab or window
  • External link opens in new tab or window
  • External link opens in new tab or window
  • External link opens in new tab or window
  • External link opens in new tab or window
  • External link opens in new tab or window
  • External link opens in new tab or window
  • External link opens in new tab or window
  • External link opens in new tab or window
  • External link opens in new tab or window

Patients FAQ4


SYSTEMS EFFECTED BY COLLAGEN



OK, its NOT just about

'brittle bones' anymore,

Can you explain more about WHAT the problem is and how to look after it?



The short answer is that collagen affects all 11 major organ systems of the human body. However, the degree of dependence varies considerably from one system to another. This is particularly important when discussing Osteogenesis Imperfecta (OI), because collagen is not simply a component of bone. It is a structural protein found throughout the body.


In fact, collagen accounts for approximately 25–30% of the body's total protein by mass, making it the most abundant protein in the human body.


There are at least 28 recognized collagen types, and different organs depend on different combinations of them. A critical distinction for OI research is that having collagen in a tissue does not necessarily mean that tissue is adversely affected by OI. The type of collagen involved, the underlying genetic variant, and the tissue's dependence on that collagen all matter.


The 11 major body systems and their relationship to collagen


The following table uses the standard 11-system anatomical classification.:


Body system                                 How collagen contributes

1. Skeletal                                Provides the organic framework of bones, supports mineralization, and contributes to cartilage, joints, and skeletal strength.

2. Muscular                             Surrounds and supports muscle fibers, transmits force, and helps connect muscles to tendons and bones.

3. Cardiovascular                   Supports blood vessel walls, heart valves, cardiac connective tissue, and arterial elasticity.

4. Respiratory                         Provides structural support and elastic recoil in the lungs, airways, and connective tissues of the chest.

5. Nervous                               Contributes to peripheral nerve sheaths, supporting membranes, and extracellular structures around nervous tissue.

6. Integumentary (skin)         Provides skin strength, resilience, and structural integrity; plays an essential role in wound repair.

7. Digestive                              Supports the walls of the esophagus, stomach, and intestines, as well as connective tissue within digestive organs.

8. Urinary                                 Supports kidney basement membranes, bladder walls, ureters, and other urinary tract structures.

9. Reproductive                      Provides structural support in reproductive organs, pelvic connective tissues, and associated ligaments.

10. Endocrine                         Forms part of the supporting extracellular matrix around hormone-producing glands and influences their tissue architecture.

11. Lymphatic / Immune      Supports lymphatic vessels, lymph nodes, spleen, and the connective tissue framework involved in immune-cell movement.



This means collagen has a structural or functional role in 11 out of 11 major body systems.

But that is only the beginning of the story, especially for OI.



Which systems are actually documented as being affected by OI?



This is where the distinction becomes particularly interesting. Although collagen contributes to all 11 systems, published OI research provides substantially stronger evidence for involvement in some systems than others.



Body system                 Evidence of OI-related effects                      Examples


Skeletal                          Well established                                            Fractures, deformities, vertebral compression


Muscular                        b                                                                        Muscle weakness, altered muscle function


Cardiovascular             Documented, with uncertainties                 Valve abnormalities, aortic enlargement


Respiratory                    Well established                                            Restrictive breathing, chest wall and possible intrinsic lung abnormalities


Nervous                           Documented                                                 Hearing loss, craniovertebral abnormalities and neurological complications


Integumentary                Documented                                               Thin skin, bruising, tissue fragility


Digestive                          Reported; mechanisms less certain     Reflux, constipation, functional GI symptoms


Urinary                              Limited direct OI evidence                       Collagen supports urinary structures, but a specific OI effect is not established broadly


Reproductive                   Documented in selected circumstances   Pregnancy and delivery complications


Endocrine                        Limited direct OI evidence                           Collagen supports glands, but a general endocrine defect from OI is not established


Lymphatic / Immune      Limited direct OI evidence                          Structural collagen involvement without a demonstrated generalized immune disorder




Research supporting these distinctions includes the 2025 GeneReviews clinical overview, a 2020 integrative review of adult OI manifestations, and a 2024 review of extraskeletal OI mechanisms.


In most cases, areas that are “Well Documented” are areas where direct research has been made and the link between OI and the issue is not ONLY well documented, but that there has been put forth an acceptable ' medical reason' for the issue. In many cases, HIGH BP for example, there are 'medical reasons' why the two could be related, but there has not been one solid theory on wjhy OI has a direct effect on patients BP. Some of this is due to the lack of funding and research dollars available to try and determine that exact link. Often times the theory was proposed when the BP issue was discovered during a research project looking at a completely unrelated issue.



Two additional areas deserve separate attention, even though they are not independent systems in the standard 11-system classification: the eyes and the auditory system. Both have well-documented OI manifestations, including blue sclera, corneal thinning, and hearing loss.



Why collagen quality versus quantity matters


In classic OI, there are two important mechanisms:


  • Quantity defect: The body produces less type I collagen, but the collagen produced may be structurally normal. This is typical of many Type I OI cases.

  • Quality defect: The body produces collagen with an abnormal molecular structure, which can disrupt fibril formation and tissue integrity. This is more typical of several moderate-to-severe OI forms.


These differences help explain why people with OI can have quite different systemic manifestations, even when they share the same general diagnosis.



There may actually be three separate 'silos' for these types of issues.



  1. Directly established effects: Conditions demonstrated to arise from OI-related abnormalities.

  2. Associated or secondary effects: Conditions seen more frequently in OI or resulting from skeletal and muscular complications, without necessarily being caused directly by abnormal collagen in that organ.

  3. Biologically plausible but unproven effects: Conditions for which collagen biology suggests a possible mechanism, but adequate OI-specific evidence is lacking.


This is especially useful when examining cardiovascular, respiratory, digestive, and vascular disorders, where the difference between an observed association and a demonstrated causal mechanism matters enormously.


The central conclusion: Collagen participates in all 11 major body systems, but we should not claim that OI has been demonstrated to damage all 11.

One particularly useful next step would be to build a system-by-system OI evidence map, identifying each documented manifestation, the proposed collagen mechanism, and the strength of published evidence. That would provide a defensible foundation for explaining why OI is a systemic connective tissue disorder rather than simply a brittle-bone disease.




  • HOME
close lightbox